U. Ruther et al., EFFICACY OF ANTIESTROGEN TREATMENT IN A BENIGN METASTASIZING LEIOMYOMA WITH PARANEOPLASTIC ESTRADIOL PRODUCTION, Oncology Reports, 3(2), 1996, pp. 293-299
Benign metastasizing leiomyoma (BML) is a rare hormone-dependent disea
se which occurs predominantly in women during their child-bearing year
s. After our patient had refused ablative hormone therapy (bilateral o
varectomy), evidence of estrogen and progesteron receptors in tumor ti
ssue taken from the lung sites, as well as extremely high estradiol se
rum levels, led us to conduct high-dosage antiestrogen therapy for 5 y
ears; daily administration of 250 mg of Tamoxpuren(R) resulted in stab
le disease of the pulmonary sites without any side effects. This also
significantly lowered estradiol serum levels, which improved clinical
symptoms. Five years later, the patient's vision suddenly deteriorated
due to bilateral macula degeneration. This forced us to stop the anti
estrogen therapy and commence alternative treatment with LHRH analogue
(3.6 mg Goreselin). We observed stable disease of the pulmonary metas
tases and low estradiol serum levels during the first 6 months of Gose
relin treatment. The response to antiestrogen therapy in BML suggests
that the muscular component of these disorders is responsive to estrog
en ablation.